Signe Borgquist
@signeborgquist
Followers
437
Following
953
Media
17
Statuses
156
Chair Professor of Oncology. Breast cancer specialist. Translational cancer researcher. @oncaarhus. @AUHdk. @AarhusUni. @lunduniversity @obecare
Aarhus, Danmark
Joined October 2019
At #ESMOBreast2025, Dr. @SixtenHarborg shared an analysis from the Nurses’ Health Study showing that weight gain after diagnosis may raise #breastcancer death risk. Study followed 6,800+ women between 1978 - 2018, with follow-up ranging from 4–15 years. 🔗 https://t.co/YrnU7QyuFw
1
2
7
Obesity➡️ worse prognosis & different biology #breastcancer. Still, BMI is only reported in 8% of 495 trials we reviewed. More research needed to study impact of BMI on treatment efficacy and toxicity🙏 ! @Josephine_VC @VanBaelenKaren @OncoAlert
https://t.co/5oRStoBQP5
link.springer.com
Breast Cancer Research - The proportion of patients with breast cancer and obesity is increasing. While the therapeutic landscape of breast cancer has been expanding, we lack knowledge about the...
2
15
41
Thank you for highlighting our research results - timely to consider metabolic screening among cancer patients! @jonasbh93 @jensbruu @ncfoDK @StenoAarhusRes @SDCOdense
📰 Patients with #breastcancer who have high levels of glycosylated hemoglobin have an increased risk of recurrence and death. #HbA1c #ESMOBreast24 👉 Read More: https://t.co/07oJhjQoLg
@myESMO #oncologynews @jensbruu
0
3
7
📄 #Breastcancer survivors with #metabolicsyndrome have shorter disease-free survival than those without metabolic syndrome. #ESMOBreast24 #oncologynews @myESMO 🗞️ Read More: https://t.co/tIjzgAopYG
0
1
5
Important point by @ErikaHamilton9. A common questions from pts is: what should I take (or eat) to reduce my risk of recurrence? The answer to this question should not come from retrospective studies, often burdened by confounding bias, but should derive from RCTs. #ESMOBreast24
3
13
50
So happy to be at the #ESMOBreast24 and share our results on the impact of metabolic syndrome on breast cancer outcomes🔬 BC patients with metabolic syndrome have poorer outcomes compared to their peers without metabolic syndrome ‼️ Read @mydocwire coverage of our study📰
📄 #Breastcancer survivors with #metabolicsyndrome have shorter disease-free survival than those without metabolic syndrome. #ESMOBreast24 #oncologynews @myESMO 🗞️ Read More: https://t.co/tIjzgAopYG
1
3
9
At #ESMOBreast24: In a Danish population-based cohort 🇩🇰 study statin use ⬇️ breast cancer mortality 💊 Validation in prospective randomized trials is needed‼️ A phase 3 trial is ongoing https://t.co/4NBPap9N4G
@OncoAlert
1
3
14
Emulated target trial looking at #statins in early #bcsm Those that received statins had ⬆️ survival. 🎯 Question is what other healthy behaviors are associated with statin use? Hard to conclude much with study design, MASTER randomized will help. #ESMOBreast24
@myESMO
2
6
30
Great morning at #ESMOBreast24 - awaiting our talented PhD-student @SixtenHarborg at @oncaarhus to talk - emulated target trial with statins in #breastcancer
1
1
13
Enjoying ESMO Breast 2024 with these amazing talents🇩🇪☀️💖 @jonasbh93 @SixtenHarborg @KaKjaergaard @Jeppe_Skovbjerg @KirstenWoolpert
#ESMOBreast24
0
4
13
Sikke en fantastisk dag! Samarbejde er ordet!
Glimt fra ph.d.-gruppens udflugt til Kræftens Bekæmpelses forskningsenhed. Det var en spændende og lærerig dag med formålet at fremme fremtidigt samarbejde på tværs af vores organisationer. Stort tak for invitationen. @cancer_dk #DanishCancerInstitute
0
0
5
Attending #SABCS2023 remotely from lovely @SkagenDenmark with this superb team of colleagues @BOffersen @TrineTramm @SixtenHarborg @jonasbh93 @Jeppe_Skovbjerg @kristinehogsbj1 @PSkovlund Martin & Lærke @oncaarhus @AarhusUni
0
2
21
Obesity Linked to Increased Recurrence Rates in Breast Cancer https://t.co/rnXaoVzHch Thanks @curetoday for the chat and for featuring our latest paper 📄
curetoday.com
In a recent study, obesity was linked to an increased risk of recurrence for patients with HR-positive, early-stage breast cancer.
0
3
19
Magnificent contributions from @SixtenHarborg @jonasbh93 @PSkovlund in the field of obesity & cancer @DCCC_ObeCaRe @oncaarhus
Inspiring to attend the DASO’s annual meeting this weekend🌟 Learned a whole lot about obesity through several multidisciplinary presentations📊 Great to see my two colleagues share their important research on obesity, survival and communication in breast cancer👏🏻
0
0
10
Powerful words in horrible times😢let”s hope the world is listening
1
0
0
Always a great privilege and joy to collaborate with such talented colleagues🙏🏻🙏🏻🙏🏻 - thank you all for all efforts to get this important publication out paving way for improving health in cancer patients ❤️
A huge thanks to my amazing supervisors @signeborgquist @DeeCroninFenton, Thomas P. Ahern and collaborators Marianne Ewerts and Maj-Britt Raaby Jensen for their great efforts in making this study happen 👩🔬👨🔬🌟
0
0
9
See our clinically important paper on obesity & inferior breast cancer prognosis - NEXT STEP: how do we circumvent this?? @SixtenHarborg @DeeCroninFenton @DCCC_ObeCaRe @oncaarhus @DCEAarhus @AUHdk @HealthAarhusUni @ncfoDK @cancer_dk
UPDATE - OBESITY & BREAST CANCER RECURRENCE‼️ This study suggests that obesity is associated with an increased risk of recurrence among patients with hormone receptor–positive breast cancer treated with aromatase inhibitors‼️ https://t.co/R4V4wgLLjT
7
5
16
🤖Artificial intelligence as an adjunct tool for breast oncologists – are we there yet? Read this new editorial just published by @IlanaSchlam Saad Menezes, Adrian Y Tan, @CCortiMD @inas_md @stolaney1 to find out! https://t.co/zTTeLa12jX
0
25
48
Super proud of #ESMOYOC team and grateful to @DrJonLim for leading on such an important position paper on role and future of the clinician-scientist in #oncology, a key topic for many YOs @ESMO_Open @myESMO @OncoAlert @AIOMtweet @TeresaSAmaral @UniGenova
https://t.co/qgaw1uvWVv
3
41
106
0
0
13